EGFR and non-small cell lung carcinoma: Additionally, Yang et al. applied MALDI-TOF-MS and ClinProTools software to identify serum peptides and proteins associated with EGFR gene mutation status in stage IIIB or IV NSCLC patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes [77].